- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Improving the analysis of composite endpoints in rare disease trials ; volume:13 ; number:1 ; day:22 ; month:5 ; year:2018 ; pages:1-9 ; date:12.2018
Orphanet journal of rare diseases ; 13, Heft 1 (22.5.2018), 1-9, 12.2018
- Creator
-
McMenamin, Martina
- Contributor
-
Berglind, Anna
Wason, James M. S.
SpringerLink (Online service)
- DOI
-
10.1186/s13023-018-0819-1
- URN
-
urn:nbn:de:101:1-2018080222421555200418
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McMenamin, Martina
- Berglind, Anna
- Wason, James M. S.
- SpringerLink (Online service)
Other Objects (12)
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Methods for planning and analyzing clinical trials with composite endpoints
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Methods for planning and analyzing clinical trials with composite endpoints
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Composite endpoints, including patient reported outcomes, in rare diseases
Composite endpoints, including patient reported outcomes, in rare diseases
Methods for planning and analyzing clinical trials with composite endpoints
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Endpoints for clinical trials in retinal diseases
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Endpoints in stem cell trials in ischemic heart failure
Surrogate endpoints in trials: a call for better reporting